CSL Limited Company Profile (ASX:CSL)

About CSL Limited

CSL Limited logoCSL Limited is a biopharmaceutical company that researches, develops, manufactures and markets biotherapies to treat and prevent serious and rare medical conditions. The principal activities of the Company include research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. The Company operates through the three segments: CSL Behring, which manufactures and develops plasma therapies (plasma products and recombinants), bioCSL, which manufactures and distributes non-plasma biotherapeutic products, and CSL Intellectual Property, which includes licensing of intellectual property generated by the Company to unrelated third parties. CSL Behring therapies are indicated for treatment of bleeding disorders including, hemophilia and von Willebrand disease, primary and secondary immune deficiencies, hereditary angioedema, neurological disorders and inherited respiratory disease. bioCSL manufactures seasonal and pandemic influenza vaccines.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: ASX
  • Symbol: CSL
  • CUSIP:
Key Metrics:
  • Previous Close: $81.04
  • 50 Day Moving Average: $107.07
  • 200 Day Moving Average: $108.92
  • Trailing P/E Ratio: 40.17
  • P/E Growth: 0.00
  • Market Cap: $49.21B
Additional Links:

Analyst Ratings

Consensus Ratings for CSL Limited (ASX:CSL) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for CSL Limited (ASX:CSL)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for CSL Limited (ASX:CSL)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for CSL Limited (ASX:CSL)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for CSL Limited (ASX:CSL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CSL Limited (ASX:CSL)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for CSL Limited (ASX:CSL)
DateHeadline
finance.yahoo.com logoJapan's Ministry of Health, Labour and Welfare (MHLW) Approves CSL Behring's IDELVION® -- The First and Only Hemophilia B Therapy with Up to 14-day Dosing Intervals (ASX:CSL)
finance.yahoo.com - September 29 at 4:21 PM
News IconAnalysts Raise Concerns over Tier 2 Banks’ Health (ASX:CSL)
www.thisdaylive.com - September 29 at 9:25 AM
openpr.com logoGlobal Vaccine Market Will Reach Around USD 59.20 Billion In 2020 (ASX:CSL)
www.openpr.com - September 29 at 9:25 AM
News IconNew Market Report: Diabetic Nephropathy - Pipeline Review, H2 2016 (ASX:CSL)
reports.pr-inside.com - September 29 at 9:25 AM
fool.com logoWill CSL Limited return to $120 per share? (ASX:CSL)
www.fool.com.au - September 29 at 9:25 AM
marketwired.com logoComstock Files Mineral Resource Estimate NI 43-101 Technical Report on SEDAR for the Preview SW Gold Project (ASX:CSL)
www.marketwired.com - September 28 at 9:20 AM
News IconRecent research: Global periodontitis pipeline 2016 market therapeutics assessment outlook (ASX:CSL)
www.whatech.com - September 28 at 9:20 AM
News IconNaira Now N445/$ on Parallel Market (ASX:CSL)
www.thisdaylive.com - September 27 at 9:03 AM
newsmaker.com.au logo2016 H2 Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Market Therapeutics Research (ASX:CSL)
www.newsmaker.com.au - September 24 at 4:14 PM
4-traders.com logoCSL : Behring Reinforces Global Leadership at the 17th Biennial Meeting of the European Society for Immunodeficiencies (ESID) (ASX:CSL)
www.4-traders.com - September 22 at 4:33 PM
capitalcube.com logoETF’s with exposure to CSL Ltd. : September 22, 2016 (ASX:CSL)
www.capitalcube.com - September 22 at 4:33 PM
News IconCSL delivers vessel to Coast Guard (ASX:CSL)
timesofindia.indiatimes.com - September 22 at 10:02 AM
News IconCSL delivers FPV, way ahead of deadline (ASX:CSL)
www.newindianexpress.com - September 21 at 5:00 PM
einnews.com logoGlobal Blood Plasma Derivatives Current market, Future Scope, Segmentation by Technology Forecast to 2027 (ASX:CSL)
www.einnews.com - September 21 at 8:41 AM
News IconAustralian market action encouraging (ASX:CSL)
www.morningstar.com.au - September 21 at 8:41 AM
fool.com logoHow CSL Limited turned a $1,000 investment into over $200,000 (ASX:CSL)
www.fool.com.au - September 16 at 4:19 PM
News IconCSL Limited Pipeline Review, Market Share, Size and Clinical trial 2016 – 2020 (ASX:CSL)
www.medgadget.com - September 16 at 4:19 PM
finance.yahoo.com logoGeneral Counsel Greg Boss of Global Biotherapeutics Leader CSL Limited Receives Career Honor from Directors Roundtable (ASX:CSL)
finance.yahoo.com - September 16 at 4:19 PM
fool.com logoWhere to next for the CSL Limited share price? (ASX:CSL)
www.fool.com.au - September 14 at 9:40 PM
News IconPreventive Vaccine Market Analysis by Types, Regions, Enduser and Forecast 2020 (ASX:CSL)
empowerednews.net - September 14 at 8:03 AM
News IconGlobal Intravenous Immunoglobulin (IVIg) Market – Estimates and Forecasts(2014 – 2020) (ASX:CSL)
www.medgadget.com - September 14 at 8:03 AM
News IconCochin Shipyard gears up for IPO (ASX:CSL)
www.newindianexpress.com - September 14 at 8:03 AM
News IconCommSec Daily Report Tuesday (ASX:CSL)
www.thebull.com.au - September 13 at 9:18 AM
4-traders.com logoWestpac Banking : Self-Funding Instalments over securities in CSL (ASX:CSL)
www.4-traders.com - September 13 at 9:18 AM
News IconResearch focused on the 2016 H2 diabetic nephropathy pipeline market key companies analysis (ASX:CSL)
www.whatech.com - September 12 at 4:15 PM
capitalcube.com logoETF’s with exposure to CSL Ltd. : September 12, 2016 (ASX:CSL)
www.capitalcube.com - September 12 at 4:15 PM
News IconPutting cells through their paces (ASX:CSL)
pursuit.unimelb.edu.au - September 12 at 9:16 AM
fool.com logoIs CSL Limited headed back to $120? (ASX:CSL)
www.fool.com.au - September 12 at 9:16 AM
News IconGlobal Vaccine Market worth USD 77.5 billion by 2024 – Industry Type, Applications & Forecasts Research Report (ASX:CSL)
www.abnewswire.com - September 10 at 9:02 AM
einnews.com logoCSL Joins RAIN RFID Alliance to Promote RAIN RFID Reader Technology (ASX:CSL)
www.einnews.com - September 10 at 9:02 AM
live-pr.com logoNew Market Report: CSL Limited (CSL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile (ASX:CSL)
www.live-pr.com - September 9 at 4:19 PM
News Icon$21b diaspora remittance: The odds against banks (ASX:CSL)
guardian.ng - September 7 at 6:59 AM
fool.com logoAre CSL Limited shares cheap today? (ASX:CSL)
www.fool.com.au - September 7 at 6:59 AM
einnews.com logoCSL Signs Agreement to License RFID Patents from Round Rock Research (ASX:CSL)
www.einnews.com - September 6 at 4:18 PM
News IconGlobal Rotavirus Vaccines Sales Market Report 2021 is released (ASX:CSL)
www.idatainsights.com - September 6 at 9:19 AM
finance.yahoo.com logoScleroderma Pipeline (Systemic Sclerosis) Market Report for H2 2016 (ASX:CSL)
finance.yahoo.com - September 6 at 9:19 AM
fool.com logoWhy I think the CSL Limited share price could keep on rising (ASX:CSL)
www.fool.com.au - September 6 at 9:19 AM
News IconVaccines Market worth 48.03 Billion USD by 2021 (ASX:CSL)
www.emailwire.com - September 4 at 8:59 AM
fool.com logoA large, mid and small cap stock I’d buy with $30,000 (ASX:CSL)
www.fool.com.au - September 2 at 4:14 PM
News IconUnited States Rotavirus Vaccines Market Report 2021: Astellas Pharma Inc, CSL Limited, Emergent BioSolutions, Inc, GlaxoSmithKline (ASX:CSL)
www.medgadget.com - September 2 at 4:14 PM
News IconGlobal Blood Plasma Derivatives Market 2016: Industry Demand, Segment, Consummation, and Research to 2021 (ASX:CSL)
www.marketingdive.com - September 1 at 4:21 PM
News IconUnited States Polio Vaccines Market Report 2021: Astellas Pharma Inc, CSL Limited, Emergent BioSolutions, Inc, GlaxoSmithKline (ASX:CSL)
www.medgadget.com - September 1 at 4:21 PM
reuters.com logoBRIEF-FDA accepts CSL Behring's Biologics license application (ASX:CSL)
www.reuters.com - September 1 at 10:33 AM
News IconUS FDA accepts CSL Behring’s BLA for first subcutaneous prophylactic therapy to prevent HAE attacks (ASX:CSL)
www.pharmabiz.com - September 1 at 10:33 AM
4-traders.com logoCSL : FDA Accepts CSL Behring's Biologics License Application for First Subcutaneous Prophylactic Therapy to Prevent Hereditary Angioedema Attacks (ASX:CSL)
www.4-traders.com - September 1 at 10:33 AM
finance.yahoo.com logoFDA Accepts CSL Behring's Biologics License Application for First Subcutaneous Prophylactic Therapy to Prevent Hereditary Angioedema Attacks (ASX:CSL)
finance.yahoo.com - August 30 at 4:25 PM
capitalcube.com logoETF’s with exposure to CSL Ltd. : August 30, 2016 (ASX:CSL)
www.capitalcube.com - August 30 at 4:25 PM
4-traders.com logoCSL : FDA Accepts CSL Behring’s BLA for First Subcutaneous Prophylactic Therapy to Prevent Hereditary Angioedema Attacks (ASX:CSL)
www.4-traders.com - August 30 at 6:49 AM
publicnow.com logoFDA Accepts CSL Behring’s BLA for First Subcutaneous Prophylactic Therapy to Prevent Hereditary Angioedema Attacks (ASX:CSL)
www.publicnow.com - August 29 at 9:40 PM
finance.yahoo.com logoSeqirus receives FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older (ASX:CSL)
finance.yahoo.com - August 29 at 4:37 PM

Social


Last Updated on 9/30/2016 by MarketBeat.com Staff